scispace - formally typeset
M

Myron S. Cohen

Researcher at University of North Carolina at Chapel Hill

Publications -  576
Citations -  50913

Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.

Papers
More filters
Journal ArticleDOI

Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1

TL;DR: The rationale for using antiretroviral therapy to prevent sexual transmission of HIV, as well as the limitations of this approach are explored.
Journal ArticleDOI

Antiretroviral pharmacology in mucosal tissues.

TL;DR: The physicochemical and biologic factors influencing ARV tissue exposure are summarized and how preclinical and clinical data might be practically translated into optimal preexposure prophylaxis dosing strategies for clinical trials testing using mathematical modeling and simulation is suggested.
Journal ArticleDOI

Highly efficient HIV transmission to young women in South Africa

TL;DR: The data from a cross-sectional national household survey of HIV among South African women aged 15–24 years was used to estimate the per-partnership transmission probability from men to women and identified the factors that may drive the efficient spread of HIV in sub-Saharan Africa.
Journal ArticleDOI

Trends of Gonorrhea and Chlamydial Infection during 1985–1996 among Active-Duty Soldiers at a United States Army Installation

TL;DR: The adjusted incidence of gonorrhea and chlamydia among Fort Bragg soldiers remained higher overall than comparable state and national rates during the period of analyses, and STDs continue to lead to significant morbidity in this representative military population.

Schistosomiasis control: experiences and lessons from China

TL;DR: The present study presents a novel and scalable approach called “informed consent” that aims to provide real-time information about the Administrator’s decision to vaccinate against HIV/AIDS in patients at risk of infection.